This slide show highlights the 2014 FDA approvals of cancer treatments, which included therapies for melanoma and lung, gastric, ovarian, and cervical cancers, as well as various hematologic malignancies.
63 Choice Architecture Bias in Genetic Counseling of Breast Cancer Patients
Administering CAR T-Cell Therapy and Bispecific Agents in Nursing Practice
Registered nurses discuss research related to agents like ciltacabtagene autoleucel presented at the 2024 Oncology Nursing Society Congress.
64 Empowering Medical Students to Deliver Breast Health Education: A Community-Based Initiative
Applying Novel Radiotherapy Technology for Brain Tumors and Other Cancers
Timothy Chen, MD, highlights how technologies such as ZAP-X and proton therapy may improve outcomes for patients with cancer.
FDA Approves Noninvasive Stool RNA Test for Colorectal Cancer Screening
Data from the phase 3 CRC-PREVENT trial support the sensitivity of ColoSense in the detection of colorectal cancer.
Zenocutuzumab Earns FDA Priority Review in NRG1+ NSCLC, Pancreatic Cancer
Data from the phase 1/2 eNRGy trial support the biologics license application for zenocutuzumab in NRG1-positive NSCLC and PDAC.